Prelude Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $613K | Hold |
|
|||||
|
2024
Q4 | $716K | Hold |
|
|||||
|
2024
Q3 | $719K | Sell |
|
|||||
|
2024
Q2 | $715K | Buy |
|
|||||
|
2024
Q1 | $788K | Sell |
|
|||||
|
2023
Q4 | $1.48M | Buy |
|
|||||
|
2023
Q3 | $538K | Buy |
|
|||||
|
2023
Q2 | $596K | Sell |
|
|||||
|
2023
Q1 | $788K | Buy |
|
|||||
|
2022
Q4 | $503K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $2K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $269K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $30K | Buy |
|
|||||
|
2015
Q1 | $17K | Buy |
|